Rekha Rao

Combined epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A and the histone deacetylase inhibitor panobinostat against human AML cells

Warren Fiskus, Yongchao Wang, Arun Sreekumar et al. · Blood · 2009 · 355 citations · Full text

RETRACTED: Coordinated Silencing of MYC-Mediated miR-29 by HDAC3 and EZH2 as a Therapeutic Target of Histone Modification in Aggressive B-Cell Lymphomas

Xinwei Zhang, Xiaohong Zhao, Warren Fiskus et al. · Cancer Cell · 2012 · 273 citations · Full text

Hematological Malignancy, Tumor Biology, Lymphoid Neoplasia +9

Auranofin Induces Lethal Oxidative and Endoplasmic Reticulum Stress and Exerts Potent Preclinical Activity against Chronic Lymphocytic Leukemia

Warren Fiskus, Nakhle S. Saba, Min Shen et al. · Cancer Research · 2014 · 243 citations · Full text

Chronic Lymphocytic Leukemia, Lipid Peroxidation, Apoptosis +22

HDAC6 inhibition enhances 17-AAG–mediated abrogation of hsp90 chaperone function in human leukemia cells

Rekha Rao, Warren Fiskus, Yonghua Yang et al. · Blood · 2008 · 186 citations · Full text

Cotreatment with panobinostat and JAK2 inhibitor TG101209 attenuates JAK2V617F levels and signaling and exerts synergistic cytotoxic effects against human myeloproliferative neoplastic cells

Yongchao Wang, Warren Fiskus, Daniel G. Chong et al. · Blood · 2009 · 177 citations · Full text